Common Treasures
Manufacturing · Nevada, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1870 Vassar St Unit 3, Reno, Nevada, 895...Website
commontreasures.shopRevenue
<$5 MillionIndustry
About Common Treasures
Is Common Treasures your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Common Treasures has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Common Treasures, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Common Treasures had a recent Job posting/layoffs
Earning: See what the market has to say on Common Treasures recently announced quarterly report
Check out if Common Treasures is spiking on competitors!
Product Launch: Get notified when Common Treasures launches new products
Funding: Get notified immidiatlly once Common Treasures has new funding data
Congratulate Masked Content for being promoted to Masked Content at Common Treasures
Recommended Actions
Find VP level buyers at Common Treasures
Find more new buyers
Compare Similar Companies to Common Treasures
Compare insights from companies similar to Common Treasures, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Common Treasures
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Common Treasures
Methocarbamol is a central muscle relaxant designed to treat acute musculoskeletal pain and muscle spasms, often used in conjunction with rest and physical therapy. It is primarily intended for adults experiencing localized, painful muscle spasms due to injuries, strains, or other conditions. The product is administered orally or via IV/IM in hospi... Read More